Status:
COMPLETED
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Cerebral Palsy
Eligibility:
All Genders
7-17 years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of the study is to confirm the functional improvement obtained through treatment of spasticity on 2 agonist and antagonist muscles. The hypothesis is that treatment of both muscles gives a bet...
Eligibility Criteria
Inclusion
- Patients between 7 to 17 years old
- Cerebral palsy children with walking ability (even with crutch or knee-walker) allowing gait analysis.
- Patients with functional status allowing the use of botulinum toxin on target muscles.
Exclusion
- Patients under 7 years old
- Patients up to 17 years old
- Patients in whom botulinum toxin is contra-indicated
- Patients who received botulinum toxin within a 6 month period before the beginning of the study
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2008
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT00133861
Start Date
April 1 2005
End Date
June 1 2008
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Edouard Herriot - Pavillon T bis
Lyon, France, 69003